Avadel Pharmaceuticals Plc financial data

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland
Fiscal year end
December 31
Former names
FLAMEL TECHNOLOGIES SA (to 12/30/2016)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 284 % +7.4%
Quick Ratio 33.5 %
Debt-to-equity 118 % -12.1%
Return On Equity -65.7 % +68.9%
Return On Assets -30.2 % +66.6%
Operating Margin -25.1 % +94.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.6M shares +0.53%
Common Stock, Shares, Outstanding 96.5M shares +7.45%
Entity Public Float 1.34B USD -8.02%
Common Stock, Value, Issued 965K USD +7.46%
Weighted Average Number of Shares Outstanding, Basic 95.1M shares +18.7%
Weighted Average Number of Shares Outstanding, Diluted 95.1M shares +18.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 169M USD +505%
Research and Development Expense 15.2M USD +14.6%
Costs and Expenses 144M USD +46.3%
Operating Income (Loss) -42.4M USD +69.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -49.1M USD +69.5%
Income Tax Expense (Benefit) -247K USD +50.7%
Net Income (Loss) Attributable to Parent -48.8M USD +69.5%
Earnings Per Share, Basic -0.51 USD/shares +74.5%
Earnings Per Share, Diluted -0.51 USD/shares +74.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51.4M USD +64.8%
Marketable Securities, Current 22.4M USD -69.7%
Accounts Receivable, after Allowance for Credit Loss, Current 34.1M USD +182%
Inventory, Net 20.3M USD +95.5%
Other Assets, Current 882K USD -60.5%
Assets, Current 134M USD +0%
Property, Plant and Equipment, Net 453K USD -22.6%
Operating Lease, Right-of-Use Asset 1.7M USD -34.3%
Goodwill 16.8M USD 0%
Other Assets, Noncurrent 11M USD +5.28%
Assets 164M USD -0.28%
Accounts Payable, Current 7.33M USD -35.9%
Accrued Liabilities, Current 40.7M USD +67.8%
Liabilities, Current 48.8M USD +32.5%
Operating Lease, Liability, Noncurrent 1.12M USD -33.6%
Other Liabilities, Noncurrent 5.18M USD -8.33%
Liabilities 90.4M USD +17.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -24.6M USD -6.1%
Retained Earnings (Accumulated Deficit) -794M USD -6.55%
Stockholders' Equity Attributable to Parent 73.8M USD -15.8%
Liabilities and Equity 164M USD -0.28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD +1.75%
Net Cash Provided by (Used in) Financing Activities 13.2M USD -61.7%
Net Cash Provided by (Used in) Investing Activities 21.4M USD +322%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.5M shares +7.45%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.63M USD -50.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.4M USD +64.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 730K USD -76.1%
Deferred Tax Assets, Valuation Allowance 102M USD +5.33%
Deferred Tax Assets, Gross 102M USD +5.33%
Operating Lease, Liability 1.7M USD -35.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.2M USD +68%
Lessee, Operating Lease, Liability, to be Paid 1.95M USD -35.8%
Operating Lease, Liability, Current 582K USD -37.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 477K USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 683K USD -37.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +12.8%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 249K USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 477K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 68.6M USD -3.5%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 2.72M USD -10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 316K USD -33.8%
Preferred Stock, Shares Outstanding 0 shares -100%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%